(PDF) Placebo Controlled Pilot Trial to Study the

Placebo Controlled Pilot Trial to Study the Remyelinating Potential of Intravenous Immunoglobulins in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom

doi 10.1136/jnnp.68.1.89

Full Text

Abstract

Available in full text

Categories

Date

January 1, 2000

Authors

Publisher

BMJ

Related search

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

New England Journal of Medicine

English

Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial

English

Oligoclonal Immunoglobulins and Multiple Sclerosis.

English

Randomised Controlled Trial Comparing Two Different Intravenous Immunoglobulins in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Journal of Neurology, Neurosurgery and Psychiatry

English

Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial

Arthritis and Rheumatology

English

Colorectal Chemoprevention Pilot Study (SWOG-9041), Randomized and Placebo Controlled: The Importance of Multiple Luminal Lesions

Clinical Colorectal Cancer

Gastroenterology

English

Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary Syndromes

Cardiovascular Medicine

English

Safety and Acceptability of Clozapine and Risperidone in Progressive Multiple Sclerosis: A Phase 1, Randomized, Blinded, Placebo-Controlled Trial

English

A Group-Delivered Self-Management Program Reduces Spasticity in People With Multiple Sclerosis: A Randomized, Controlled Pilot Trial

Multiple Sclerosis Journal – Experimental, Translational and Clinical

English